Alex Rodriguez, Others Suspended By MLB For Drugs06:08
Download

Play
New York Yankees' Alex Rodriguez is pictured during a minor league baseball rehab start with the Trenton Thunder, Saturday, Aug. 3, 2013 in Trenton, N.J. (Rich Schultz/AP)
New York Yankees' Alex Rodriguez is pictured during a minor league baseball rehab start with the Trenton Thunder, Saturday, Aug. 3, 2013 in Trenton, N.J. (Rich Schultz/AP)

Alex Rodriguez was suspended through 2014 and All-Stars Nelson Cruz, Jhonny Peralta and Everth Cabrera were banned 50 games apiece Monday when Major League Baseball disciplined 13 players in a drug case - the most sweeping punishment since the Black Sox scandal nearly a century ago.

Ryan Braun's 65-game suspension last month and previous punishments bring to 18 the total number of players disciplined for their relationship to Biogenesis of America, a closed anti-aging clinic in Florida accused of distributing banned performing-enhancing drugs.

The harshest penalty was reserved for Rodriguez, a three-time Most Valuable Player and baseball's highest-paid star. His suspension covers 211 games. Rodriguez has until Thursday to appeal, and if he does, he will remain eligible to play until a decision by the arbitrator.

The New York Yankees slugger admitted four years ago that he used performance-enhancing drugs while with Texas from 2001-03 but has repeatedly denied using them since.

Rodriguez was suspended under both the drug agreement and labor contract.

MLB said the drug penalty was for "his use and possession of numerous forms of prohibited performance-enhancing substances, including testosterone and human growth hormone over the course of multiple years."

His penalty under the labor contract was "for attempting to cover up his violations of the program by engaging in a course of conduct intended to obstruct and frustrate the office of the commissioner's investigation."

The other 12 players have already agreed to their 50-game penalties.

Guest

This segment aired on August 5, 2013.

Support the news

+Join the discussion
TwitterfacebookEmail

Support the news